Precigen Inc (PGEN)
1.41
+0.01
(+0.71%)
USD |
NASDAQ |
Apr 26, 16:00
1.41
0.00 (0.00%)
After-Hours: 16:49
Precigen Revenue (Quarterly): 1.228M for Dec. 31, 2023
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 1.228M |
| September 30, 2023 | 1.379M |
| June 30, 2023 | 1.767M |
| March 31, 2023 | 1.851M |
| December 31, 2022 | 1.763M |
| September 30, 2022 | 16.72M |
| June 30, 2022 | 2.911M |
| March 31, 2022 | 5.513M |
| December 31, 2021 | 3.684M |
| September 30, 2021 | 3.333M |
| June 30, 2021 | 3.815M |
| March 31, 2021 | 24.51M |
| December 31, 2020 | 19.33M |
| September 30, 2020 | 23.58M |
| June 30, 2020 | 30.42M |
| March 31, 2020 | 29.84M |
| December 31, 2019 | -41.73M |
| September 30, 2019 | 18.30M |
| June 30, 2019 | 32.84M |
| March 31, 2019 | 22.58M |
| December 31, 2018 | 33.79M |
| September 30, 2018 | 32.45M |
| June 30, 2018 | 45.28M |
| March 31, 2018 | 39.67M |
| Date | Value |
|---|---|
| December 31, 2017 | 65.51M |
| September 30, 2017 | 46.02M |
| June 30, 2017 | 54.43M |
| March 31, 2017 | 53.75M |
| December 31, 2016 | 46.00M |
| September 30, 2016 | 48.98M |
| June 30, 2016 | 52.50M |
| March 31, 2016 | 43.44M |
| December 31, 2015 | 41.50M |
| September 30, 2015 | 53.37M |
| June 30, 2015 | 44.89M |
| March 31, 2015 | 33.85M |
| December 31, 2014 | 31.09M |
| September 30, 2014 | 21.20M |
| June 30, 2014 | 11.79M |
| March 31, 2014 | 7.854M |
| December 31, 2013 | 7.143M |
| September 30, 2013 | 6.042M |
| June 30, 2013 | 6.69M |
| March 31, 2013 | 3.885M |
| December 31, 2012 | 6.505M |
| September 30, 2012 | 2.925M |
| June 30, 2012 | 2.726M |
| March 31, 2012 | 1.618M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
-41.73M
Minimum
Dec 2019
32.84M
Maximum
Jun 2019
9.530M
Average
3.815M
Median
Jun 2021
Revenue (Quarterly) Benchmarks
| Cyclacel Pharmaceuticals Inc | 0.031M |
| HealthEquity Inc | 262.39M |
| Corvus Pharmaceuticals Inc | -- |
| Oragenics Inc | -- |
| MAIA Biotechnology Inc | -- |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -33.06M |
| Total Expenses (Quarterly) | 24.62M |
| EPS Diluted (Quarterly) | -0.13 |
| Enterprise Value | 285.63M |
| Gross Profit Margin (Quarterly) | -10.59% |
| Profit Margin (Quarterly) | -2.69K% |
| Earnings Yield | -27.66% |
| Normalized Earnings Yield | -24.60 |